Neuroscience

Articles and news from the latest research reports.

99 notes

Researchers publish one of the longest longitudinal studies of cognition in MS
Researchers at Kessler Foundation and the Cleveland Clinic have published one of the longest longitudinal studies of cognition in multiple sclerosis (MS). The article, “Cognitive impairment in multiple sclerosis: An 18-year follow-up study,” was epublished by Multiple Sclerosis and Related Disorders on April 13, 2014. Results provide insight into the natural evolution of cognitive changes over time, an important consideration for researchers and clinicians. Authors are Lauren B. Strober, PhD, of Kessler Foundation and  Stephen M. Rao, PhD, Jar-Chi Lee, Elizabeth Fisher, PhD, and Richard Rudick, MD, of the Cleveland Clinic.
“While cognitive impairment is known to affect 40 to 65% of individuals with MS, few studies have followed the pattern of cognitive decline over time, which is important for understanding long-term care and outcomes associated with MS,” said Dr. Strober, senior research scientist at Kessler Foundation. “Our study was based on a unique sample of 22 patients who underwent neuropsychological testing at entry into the original phase 3 clinical trial of intramuscular interferon beta-1a, and again at 18-year followup.”
At baseline, 9 patients (41%) had cognitive impairment; at 18-year followup, 13 patients (59%), were found to be impaired. Significant declines over time were found in information processing speed, auditory attention, memory, episodic learning and visual construction. Decline was steeper in the unimpaired than in the impaired group, as indicated by the Symbol Digit Modalities Test (SDMT).
"These longitudinal data contribute substantially to our knowledge of the course of cognitive decline in MS,” noted John DeLuca, PhD, VP of Research & Training at Kessler Foundation. “In light of the young age at diagnosis, this perspective is fundamental to the development of rehabilitation strategies that meet the needs of people dealing with the cognitive effects of MS.”
The study was funded by Biogen Idec.

Researchers publish one of the longest longitudinal studies of cognition in MS

Researchers at Kessler Foundation and the Cleveland Clinic have published one of the longest longitudinal studies of cognition in multiple sclerosis (MS). The article, “Cognitive impairment in multiple sclerosis: An 18-year follow-up study,” was epublished by Multiple Sclerosis and Related Disorders on April 13, 2014. Results provide insight into the natural evolution of cognitive changes over time, an important consideration for researchers and clinicians. Authors are Lauren B. Strober, PhD, of Kessler Foundation and  Stephen M. Rao, PhD, Jar-Chi Lee, Elizabeth Fisher, PhD, and Richard Rudick, MD, of the Cleveland Clinic.

“While cognitive impairment is known to affect 40 to 65% of individuals with MS, few studies have followed the pattern of cognitive decline over time, which is important for understanding long-term care and outcomes associated with MS,” said Dr. Strober, senior research scientist at Kessler Foundation. “Our study was based on a unique sample of 22 patients who underwent neuropsychological testing at entry into the original phase 3 clinical trial of intramuscular interferon beta-1a, and again at 18-year followup.”

At baseline, 9 patients (41%) had cognitive impairment; at 18-year followup, 13 patients (59%), were found to be impaired. Significant declines over time were found in information processing speed, auditory attention, memory, episodic learning and visual construction. Decline was steeper in the unimpaired than in the impaired group, as indicated by the Symbol Digit Modalities Test (SDMT).

"These longitudinal data contribute substantially to our knowledge of the course of cognitive decline in MS,” noted John DeLuca, PhD, VP of Research & Training at Kessler Foundation. “In light of the young age at diagnosis, this perspective is fundamental to the development of rehabilitation strategies that meet the needs of people dealing with the cognitive effects of MS.”

The study was funded by Biogen Idec.

Filed under MS cognitive impairment cognition psychology neuroscience science

  1. eatsleepbreathe-write reblogged this from neurosciencestuff
  2. themurdockstudy reblogged this from neurosciencestuff
  3. ute-to-be reblogged this from neurosciencestuff
  4. strayblossoms reblogged this from dynastylnoire
  5. schizo321437 reblogged this from schizo321437
  6. truwordz9 reblogged this from neurosciencestuff
  7. brainterrain reblogged this from neurosciencestuff
  8. beauvale reblogged this from neurosciencestuff
  9. lunarmystery reblogged this from neurosciencestuff
  10. carleshah reblogged this from neurosciencestuff
  11. holy-shit-8 reblogged this from neurosciencestuff
  12. msoyinda reblogged this from dynastylnoire
  13. el-arbol-del-olvido reblogged this from neurosciencestuff
  14. sharkinacrowdedroom reblogged this from neurosciencestuff
  15. wolvensnothere reblogged this from samhainnight
  16. samhainnight reblogged this from neurosciencestuff
  17. kcal113 reblogged this from neurosciencestuff
  18. oliveyouidoxiii reblogged this from neurosciencestuff
  19. grabmylabcoat reblogged this from neurosciencestuff
free counters